Medicine Biz Mirador Wraps $250M Funding Round
By Jade Martinez-Pogue · January 12, 2026, 12:00 PM EST
San Diego-based clinical-stage precision medicine company Mirador Therapeutics Inc. announced Monday that it closed its Series B funding round with $250 million of investor commitments, bringing the company's total capital raised...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login